Prostate and Urologic Cancer Clinical Trials

Titlesort descending Intervention NCT ID Sponsor Status
PROSTVAC (PSA-TRICOM) in Preventing Disease Progression in Patients With Localized Prostate Cancer... Laboratory Biomarker Analysis, Placebo Administration, Rilimogene Galvacirepvec NCT02326805 National Cancer Institute (NCI) Active, not recruiting